You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
A Growing Epidemic:
A Growing Epidemic:
Atrial Fibrillation (AFib)
AFib is an irregular heart rhythm that is quickly placing critical burden on patients and healthcare systems.
MEDIA
Atrial Fibrillation (AFib)
AFib is an irregular heart rhythm that is quickly placing critical burden on patients and healthcare systems.
32% of global deaths are caused by cardiovascular disease.1
85% of these deaths were due to heart attack and stroke, and AFib increases the risk for stroke.1,3
If left untreated, AFib can lead to other conditions3.
The worldwide prevalence of AFib has increased by 33% during the last 20 years4, placing a huge burden across the globe.
AFib in Asia-Pacific
AFib currently effects2:
By 2050, AFib is expected to affect 72 Million people,5,6
That's more than twice as many AFib patients as Europe and North America combined.
For healthcare systems across APAC, every 10 years there is a 1.8-5.6x increase in healthcare costs due to Afib.7,8,9,10,11
By 2030, the number of people with AFib is expected to increase up to 70%.12
In these European nations, AFib is almost as common as stroke and cancer13.
AFib increasingly places a critical financial burden on the healthcare system, costing €660-€3,286 million annually across European countries14,15,16,17,18
It is estimated that up to 2.6% of total annual healthcare expenditure is associated with AFib in European countries.19
AFib prevalence is expected to increase by 30% by 2035.20
Yearly, AFib is the reason for:
795k strokes21
479k new AFib hospitalizations21
$35.7B in medical costs21
537k ER visits22
AFib in Latin America
AFib affects2:
AFib is one of the Top 4 cardiovascular diseases most common in Latin America23
The rate of AFib-related strokes in South America is comparable to that of Western Europe and the U.S., however, the 1-year mortality risk was almost 2x as high.24,i
In 2015, AFib had an economic burden estimated at $2.4 billion (USD) in LATAM.25
AFib is a progressive disease that may get worse over time so early diagnosis and treatment is essential for overcoming this global epidemic.
Medications are often the first attempt at treating AFib, but if medications don’t work, catheter ablation is recommended.
Catheter ablation
A minimally invasive procedure performed by heart rhythm specialists that can improve your quality of life with the following benefits:
Improvement in quality of life26
Permanent symptom relief26
Elimination of long-term risk of stroke and death normally associated with AFib27
For more information about AFib causes, symptoms and treatment options, talk to your doctor or visit www.getsmartaboutafib.net/global (outside the U.S.) or www.GetSmartAboutAFib.com (in the U.S.).